miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways

by Besskaya, V., Bi, G., Bian, Y., Chen, Z., Huang, Y., Jin, X., Liang, J., Lu, T., Tan, L., Wang, Q., Zhan, C., Zhang, H., Zhao, M., Zheng, Y.
Published 2022